Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Revenue (2017 - 2025)

Nutex Health's Revenue history spans 16 years, with the latest figure at $151.7 million for Q4 2025.

  • For Q4 2025, Revenue fell 41.12% year-over-year to $151.7 million; the TTM value through Dec 2025 reached $875.3 million, up 82.37%, while the annual FY2025 figure was $875.3 million, 82.36% up from the prior year.
  • Revenue for Q4 2025 was $151.7 million at Nutex Health, down from $267.8 million in the prior quarter.
  • Across five years, Revenue topped out at $318.7 million in Q4 2021 and bottomed at $1.5 million in Q1 2022.
  • The 5-year median for Revenue is $68.6 million (2023), against an average of $112.3 million.
  • The largest annual shift saw Revenue surged 33603.13% in 2021 before it tumbled 83.14% in 2022.
  • A 5-year view of Revenue shows it stood at $318.7 million in 2021, then tumbled by 83.14% to $53.7 million in 2022, then increased by 29.68% to $69.7 million in 2023, then skyrocketed by 269.77% to $257.6 million in 2024, then plummeted by 41.12% to $151.7 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Revenue are $151.7 million (Q4 2025), $267.8 million (Q3 2025), and $244.0 million (Q2 2025).